BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25108215)

  • 1. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.
    McNeil MM; Gee J; Weintraub ES; Belongia EA; Lee GM; Glanz JM; Nordin JD; Klein NP; Baxter R; Naleway AL; Jackson LA; Omer SB; Jacobsen SJ; DeStefano F
    Vaccine; 2014 Sep; 32(42):5390-8. PubMed ID: 25108215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.
    Moro PL; Li R; Haber P; Weintraub E; Cano M
    Expert Opin Drug Saf; 2016 Sep; 15(9):1175-83. PubMed ID: 27268157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.
    Lee GM; Greene SK; Weintraub ES; Baggs J; Kulldorff M; Fireman BH; Baxter R; Jacobsen SJ; Irving S; Daley MF; Yin R; Naleway A; Nordin JD; Li L; McCarthy N; Vellozzi C; Destefano F; Lieu TA;
    Am J Prev Med; 2011 Aug; 41(2):121-8. PubMed ID: 21767718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
    Moro PL; Haber P; McNeil MM
    Expert Rev Vaccines; 2019 Oct; 18(10):1091-1101. PubMed ID: 31580725
    [No Abstract]   [Full Text] [Related]  

  • 9. Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population.
    Sukumaran L; McCarthy NL; Li R; Weintraub ES; Jacobsen SJ; Hambidge SJ; Jackson LA; Naleway AL; Chan B; Tao B; Gee J
    Vaccine; 2015 Aug; 33(36):4446-50. PubMed ID: 26209836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team.
    Mullooly J; Drew L; DeStefano F; Chen R; Okoro K; Swint E; Immanuel V; Ray P; Lewis N; Vadheim C; Lugg M
    Am J Epidemiol; 1999 Jan; 149(2):186-94. PubMed ID: 9921964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza.
    McCarthy NL; Gee J; Weintraub E; Donahue JG; Nordin JD; Daley MF; Naleway A; Henninger M; Baxter R; Crane B; Aukes L; Wagner N; Fisher S; Jacobsen SJ; Sy L; Baggs J
    Vaccine; 2011 Jul; 29(31):4891-6. PubMed ID: 21596088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
    Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
    Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
    Glanz JM; Newcomer SR; Jackson ML; Omer SB; Bednarczyk RA; Shoup JA; DeStefano F; Daley MF
    Vaccine; 2016 Feb; 34 Suppl 1():A1-A29. PubMed ID: 26830300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
    Niu MT; Rhodes P; Salive M; Lively T; Davis DM; Black S; Shinefield H; Chen RT; Ellenberg SS
    J Clin Epidemiol; 1998 Jun; 51(6):503-10. PubMed ID: 9635999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.
    Chen RT; Glasser JW; Rhodes PH; Davis RL; Barlow WE; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Vadheim CM; Marcy SM; Ward JI; Wise RP; Wassilak SG; Hadler SC
    Pediatrics; 1997 Jun; 99(6):765-73. PubMed ID: 9164767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International collaboration to assess the risk of Guillain BarrĂ© Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.
    Groom HC; Crane B; Naleway AL; Weintraub E; Daley MF; Wain K; Beth Kurilo M; Burganowski R; DeSilva MB; Donahue JG; Glenn SC; Goddard K; Jackson ML; Kharbanda EO; Lewis N; Lou Y; Lugg M; Scotty E; Sy LS; Williams JTB; Irving SA
    Vaccine; 2022 Jan; 40(5):752-756. PubMed ID: 34980508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.
    Chen RT; DeStefano F; Davis RL; Jackson LA; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Vadheim CM; Ward JI; Marcy SM
    Bull World Health Organ; 2000; 78(2):186-94. PubMed ID: 10743283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.